Scientific Journal for Damietta Faculty of Science 13(3) 2023, 8-15
doi: 10.21608/SJDFS.2023.248290.1144
ISSN Print 2314-8594
ISSN Online 2314-8616
https://sjdfs.journals.ekb.eg/
Association of IL-6 rs1800795 and IL-1 β rs16944 Polymorphisms with
non-small Cell Lung Cancer in the Egyptian Population: a Pilot Study
Yomna F. Metwally*1, Rasha F. Zahran1, Rana R. Elsadda1, Sherif Refaat2 and Afaf M. Elsaid3
1
Biochemistry Department, Faculty of Science, Damietta University, Damietta, Egypt.
Oncology Department, Oncology Center, Mansoura University, Mansoura, Egypt.
3
Genetics Unit, Children Hospital, Mansoura University, Mansoura, Egypt.
2
Received: 13 November 2023 /Accepted: 30 November 2023
*
Corresponding author’s E-mail: fawzy.yomna89@gmail.com
Abstract
Lung cancer is a serious health and life issue, with the highest rates of incidence and mortality in the
world. It is now clear that inflammation is a key factor involved in all aspects of carcinogenesis,
notably lung cancer development. Genetic changes, including polymorphisms in inflammatory
genes, are supposed to play a significant role in increasing lung cancer risk. In this study, we aim to
investigate the association of IL-6 rs1800795 and IL-1β rs16944 polymorphisms with non-small cell
lung cancer (NSCLC) development in the Egyptian population. The study design was composed of
100 NSCLC cases and 100 controls, which were genotyped using the ARMS-PCR technique,
electrophoresed on a 2.5% agarose gel, and visualized using ethidium bromide under ultraviolet
illumination. The IL-1β rs16944 genotypes were significantly different in NSCLC patients as
compared to healthy controls (p = 0.032). Whereas the genotypes and alleles of the IL-6 rs1800795 were not
significantly linked to NSCLC incidence (p = 0.726; p = 0.822, respectively). To our best
knowledge, this study aimed to uncover the great impact of IL-1β rs16944 genotypes on NSCLC
development in the Egyptian population; thus, it may be a gateway for earlier NSCLC prevention.
Keywords: Lung cancer; polymorphism; IL-6; IL-1β; Egypt.
approximately 2.2 million new cases (11.4% of
total cancers) (Kaanane et al., 2022). In Egypt,
lung cancer represents the fastest-growing
tumor with a male-to-female ratio of 3.2:1. By
increasing the number of women smokers, the
incidence rates of lung cancer in women have
been elevated (El-Moselhy and Elrifai, 2018).
Among all lung malignancies, NSCLC
constitutes 85% and comprises three major
types of adenocarcinoma (AC), squamous cell
carcinoma (SCC), and large cell carcinoma
Introduction
Lung cancer stands as the most fatal
malignant tumor, which poses a risky health and
life conundrum all over the world. Lung cancer
has the highest fatality rate and is the secondmost commonly diagnosed cancer. In 2020,
there were almost 1.8 million lung cancer
deaths (18% of all cancer deaths) and
8
Association of IL-6 rs1800795 and IL-1 β rs16944 …
Scientific Journal for Damietta Faculty of Science 13(3) 2023, 8-15
(LCC). Unfortunately, most NSCLC patients
are not diagnosed until late-stage (IIIB-IV)
disease is present, with a five-year survival rate
of only 0%–10% (Duma et al., 2019).
According to epidemiological studies,
smoking is the most well-known risk factor for
developing lung cancer, accounting for more
than 80% of cases (El-Moselhy and Elrifai,
2018). Previous studies demonstrated that the
complex combination of chemicals in cigarette
smoke causes an inflammatory stress response,
producing a continuous source of tumor
initiators and promoters in the lung milieu
(Landvik et al., 2009). Further research
revealed a link between inflammation and
tumors, which is largely modulated by various
inflammatory cytokines (Tan et al., 2021).
Interleukin-6 (IL-6) is a multifactorial
interleukin frequently released by monocytes
and macrophages (Dutkowska et al., 2021). It is
a powerful cytokine that has both proinflammatory and anti-inflammatory properties
(Campa et al., 2005). Regarding tumorigenesis,
IL-6 functions as an autocrine growth factor for
tumours, which directly prevents apoptosis by
deleting cell cycle genes (Silva et al., 2017).
The IL-6 gene lies on the short arm of
human chromosome 7 (7p21) (Padrón-Morales
et al., 2014). The promoter of the human IL6 gene contains several single-nucleotide
polymorphisms (SNPs), among them the IL-6174G>C (rs1800795), which is the most
commonly studied variant (González-Castro et
al., 2019). A growing body of research has
revealed that IL-6 rs1800795 is linked with
increased vulnerability to multiple cancers
(Harun-Or-Roshid et al., 2021) as well as the
prognosis of several malignancies such as
NSCLC, ovarian, bladder, neuroblastoma, and
breast cancers (Almolakab et al., 2022; Zhai et
al., 2017).
Interleukin-1β (IL-1β) is a member of
the IL-1 cytokine family, which is primarily
generated by macrophages, monocytes, and
lung epithelia (Eaton et al., 2018). It is a proinflammatory cytokine that mainly regulates
cell proliferation, differentiation, and apoptosis.
It has a significant role in enhancing the
expression of several inflammatory genes,
involving IL-6, IL-17A, and IL-22 cytokines (Li
and Wang, 2013).
The IL-1β gene is located on the IL-1
gene cluster on chromosome 2q (2q14-21).
Multiple polymorphisms of the IL-1β gene have
been recognized (Li et al., 2015). IL-1β511C>T (rs16944) has been proposed to
modulate lung cancer risk, and its functional
role has been broadly studied (Zienolddiny et
al., 2004). Indeed, the identification of
polymorphisms in inflammatory genes has
attracted much attention from several
researchers, particularly for understanding
inter-individual differences in lung cancer
susceptibility, risk evaluation, and cancer
prevention or detection (Bhat et al., 2014).
Therefore, this study aimed to
determine the influence of the two genetic
variants IL-6 rs1800795 and IL-1β rs16944 on
developing NSCLC in the Egyptian population.
Material and methods
Patients' populations
A total of 200 subjects were recruited
for this pilot study, which was divided into 100
primarily diagnosed patients with NSCLC and
100 ethnically matched healthy volunteers as
controls. The patient group was enrolled on
the basis of being over 18, having a confirmed
histologic or cytological diagnosis of NSCLC
(grades I–III), adequate organ function,
measurable disease on computed tomography
(stages I–IV), no previous treatment, available
clinical data, and no history of cancer or
metastatic carcinoma. The absence of a clinical
or family history of cancer or pulmonary
diseases was necessary to be considered in the
control group.
Data collection
Written acceptance was collected from
all participants after receiving approval by the
Institution Review Board (IRB) of the Faculty
of Medicine, Mansoura University, with code
number (R.22.06.1736). This research was
accomplished pursuant to the Declaration of
Helsinki. Using patients’ records, we collected
their clinical data, including age, sex, smoking
status (nonsmoker and smoker), family history
of lung cancer, surgical history, medical
history, and symptoms.
Genotyping analysis
Information and details about the SNPs
analyzed in our study are represented in Table
9
Association of IL-6 rs1800795 and IL-1 β rs16944 …
Scientific Journal for Damietta Faculty of Science 13(3) 2023, 8-15
1. Primarily, DNA extraction was done for the
two cases and control groups. Then, genotyping
of the IL-6 rs1800795 was evaluated using the
amplification refractory mutation system
polymerase chain reaction (ARMS-PCR)
method, where three different primers were
used: one common and two other allele-specific
primers (Elsaid et al., 2014). For the genotyping
of IL-1β rs16944, the tetra primer amplification
refractory mutation system polymerase chain
reaction (T-ARMS-PCR)
method
was
performed with two outer primers and two other
allele- specific primers (Okayama et al., 2005).
Fig. 2 Photomicrograph showing genotyping
products of IL-1β (rs16944) using ARMS PCR.
Lanes (7,8), (9,10), and (11,12) identified
heterozygotes (CT); lanes (1,2) and (5,6) identified
common homozygotes (CC); lanes (3,4) and (13,14)
labeled rare homozygotes (TT). The C-allele is
visualized at 141 bp, and the T-allele is visualized at
217 bp. L 100 bp DNA ladder.
Table 1. Information about the SNPs analyzed in our
study population.
SNPs ID Gene Chromosome Cytogenetic SNP GMAF
location Region
rs1800795 IL-6
Chr7:
7p15.3 -174G>C 0.14
rs16944
22727026
IL-1β
Chr2:
2q14.1 -511C>T 0.49
112837290
Statistics
The IBM Statistical Package for Social
Science (SPSS; version 25.0) was used for
statistical tests. We processed the qualitative
variables as numbers and percentages (N %),
which were compared using Fisher’s exact test.
Testing for Hardy–Weinberg equilibrium
(HWE) was evaluated when the observed and
expected genotypic counts of both IL-6
rs1800795 and IL-1β rs16944 were compared
among cases and controls by the Chi-square
test. The allele and genotype frequencies of IL6 and IL-1β SNPs were analyzed by Fisher’s
exact test. A two-sided P value less than 0.05
indicated a significant association in all
statistical tests.
SNP single nucleotide polymorphism; Chr chromosome;
GMAF global minor allele frequency
The
PCR
products
were
electrophoresed on a 2.5% agarose gel and
visualized using ethidium bromide under
ultraviolet illumination. The PCR products of
the IL-6 rs1800795 were observed at 230 bp for
the G-allele and the C-allele, as presented in
Fig. 1. The IL-1β gene products were identified
at 141 bp for the C-allele and 217 bp for the Tallele, as illustrated in Fig. 2.
Results
Characteristics of the study subjects
Totally, 200 subjects were included in
the study, classified as 100 NSCLC patients and
100 healthy volunteers. NSCLC cases included
males of 61% and females of 39%, while the
control group had males of 84% and females of
16%. Our cases involved 49% smokers and
51% nonsmokers, while the control comprised
28% smokers and 72% nonsmokers. A
significant variance was obtained in sex,
smoking habits, family history, and medical
history between the cases and controls (p <
0.05). The two groups were matched in terms of
age and surgical history subgroups (p > 0.05).
Detailed clinical data for NSCLC cases and
controls are shown in Table 2.
Fig. 1 Photomicrograph showing genotyping
products of IL-6 (rs1800795) using ARMS PCR.
Lanes (1,2), (3,4), (5,6), (7,8), and (11,12) represent
common homozygotes (GG); lanes (13,14) represent
heterozygotes (GC); lanes (9,10) represent rare
homozygotes (CC). Both the G-allele and the Callele appeared at 230 bp. L 100 bp DNA ladder.
10
Association of IL-6 rs1800795 and IL-1 β rs16944 …
Scientific Journal for Damietta Faculty of Science 13(3) 2023, 8-15
Table 2. Characteristics of non-small cell lung
cancer (NSCLC) cases versus controls.
protective heterozygote that may be related to
the Egyptian population.
Parameter
Table 3. Distribution of IL-6 (rs1800795) -174C>G
polymorphism among Egyptian patients with
(NSCLC) compared to controls.
Age (years)
<55
>=55
Sex
Female
Male
Smoking
Smoker
Cases
(n=100)
Controls
(n=100)
P value
44
56
52
48
0.322
39
61
16
84
< 0.001
49
28
0.002
IL-6
Polymorphism
genotype
Genotype
GG
GC
CC
G
Allele
Nonsmoker
51
72
Family history
Positive
9
0
0.003
Negative
91
100
Surgical history
Positive
35
26
0.219
Negative
65
74
Medical history
Positive
55
38
0.023
Negative
45
62
Symptoms
Cough
38/62
(Positive/Negative)
Dyspnea
35/65
(Positive/Negative)
Chest
pain 29/71
(Positive/Negative)
Hemoptysis
7/93
(Positive/Negative)
Fisher’s exact test; bold values signify p < 0.05.
C
HWE
Cases
(n)%
Controls P value
(n)%
78 (78) 81 (81) 0.726
21 (21) 19 (19)
1 (1)
0 (0)
177 181 (90.5) 0.822
(88.5)
23 (11.5) 19 (9.5)
X2= 0.08, X2=1.1,
P=0.965 P=0.3
Fisher’s exact test; HWE Hardy-Weinberg equilibrium
As shown in Table 4, the genotypic and
allelic statistics of the IL-1β rs16944 variant
among NSCLC patients and controls were
established. The results of rs16944 genotypes
revealed a significant difference in NSCLC
patients other than healthy controls (p = 0.032).
Table 4. Distribution of IL-1β (rs16944) -511 C/T
polymorphism among Egyptian patients with
(NSCLC) compared to controls.
IL-1β
Polymorphism
genotype
Genotype
CC
CT
TT
C
T
Cases
(n)%
Controls P value
(n)%
10 (10)
2 (2)
0.032
86 (86) 96 (96)
4 (4)
2 (2)
allele
106 (53) 100 (50) 0.777
94 (47) 100 (50)
HWD
X2=52.7, X2=84.6,
P< 0.001 P< 0.001
Fisher’s exact test; HWE Hardy-Weinberg equilibrium;
Bold values express the p < 0.05.
Association between IL-6 (rs1800795)
polymorphism and NSCLC risk
The expected and observed frequencies
of IL-6-174G>C (rs1800795) were in
accordance with the Hardy-Weinberg equation
in the patient and control groups (p > 0.05). The
relation between the IL-6 rs1800795 variant and
NSCLC occurrence was evaluated, as presented
in Table 3. The results showed a low frequency
of the rare genotype ‘CC’ (1%) among NSCLC
patients and its absence among controls (0%),
with a non-significant variance of the genotypes
between NSCLC patients and controls (p =
0.726).
Discussion
Cytokines are a group of functional
proteins that are induced in both inflammatory
cells and cancerous cells. They have gained
considerable attention, particularly for being
important orchestrators of cancer-inflammation
interactions. It has been shown that some
inflammatory cytokines are crucial for
continuing
inflammatory
conditions,
modulating the transition to malignant
epithelial cells, hindering host immune
surveillance, and stimulating tumor growth and
spread (Bai et al., 2013). In light of the growing
research that focuses on the etiologic role of
inflammation in lung malignancies, we
conducted this study to consider the possible
impact of polymorphisms in inflammatory
Association between IL-1β (rs16944)
polymorphism and NSCLC risk
When
IL-1β-511C>T
(rs16944)
frequencies were tested for genetic equilibrium
using the Hardy-Weinberg law, they
significantly
deviated
from
expected
frequencies (p < 0.001) in both cases and
controls. This significant deviation may be
attributable to the higher frequency of the
11
Association of IL-6 rs1800795 and IL-1 β rs16944 …
Scientific Journal for Damietta Faculty of Science 13(3) 2023, 8-15
genes, such as IL-6 (rs1800795) and IL-1β
(rs16944), on NSCLC development in Egyptian
subjects.
This study demonstrated that males
have a higher incidence of NSCLC than
females. Our results were in line with evidence
from epidemiological studies, which revealed
that more men than women smoke tobacco and
have higher rates of incidence and mortality.
However, non-smoking women are more
vulnerable to evolving lung cancer than nonsmoking men, and females with NSCLC have
higher rates of EGFR mutations and the
prevalence of adenocarcinomas with lepidic
features (de Groot et al., 2018).
In addition, the study revealed other
risk factors associated with the incidence of
NSCLC, including smoking habits, family
history, and other comorbidities. As evidenced
in many reports, they are the most brilliant and
independent risk factors that can affect the
pathogenesis, outcomes, and prognosis of lung
cancer (El-Moselhy and Elrifai, 2018; North
and Christiani, 2013)
This study identified that there was a
non-significant variation between the IL-6
rs1800795 polymorphism and NSCLC
susceptibility. Several studies were in line with
our findings. A report by Gao et al. (2020),
revealed no genotypic distribution differences
for IL-6 rs1800795 in lung cancer patients using
meta-analysis. Eaton et al. (2018) conducted a
nested case-control study, comprising 625 cases
and 625 matched controls, which revealed a
non-significant correlation between genotypes
of the IL-6 rs1800795 variant and lung cancer
risk (P = 0.97, for genotypes). Also, Liu et al.
(2015) established a meta-analysis study that
showed that genotypic and allelic frequencies of
the IL-6 rs1800795 were not statistically
associated with lung cancer susceptibility. A
comprehensive meta-analysis showed that
rs1800795 was generally linked to the cancer
risk of both Africans and Asians via different
inherited models. However, the stratifying
analysis based on cancer subtypes revealed no
significant relationship with lung cancer, which
may be due to heterogeneity (Harun-Or-Roshid
et al., 2021). This was observed in Asians, who
have lower or even absent IL-6-174C allele
frequencies than Caucasians (Tian et al., 2015).
Our results were inconsistent with
those of Kaanane et al. (2022) who studied the
effect of the IL-6 (rs1800795) SNP on 150 lung
cancer cases and 150 controls in the Moroccan
population. The study revealed a significant
difference in IL-6 (rs1800795) genotypes and
alleles between cases and controls. In addition,
a meta-analysis study has confirmed that the IL6 rs1800795 has a significant linkage with
elevated lung cancer incidence (P = 0.003, for
alleles) and in Caucasian and Asian populations
(P < 0.001, P = 0.003, for alleles, respectively)
(Peng et al., 2018).
On the other hand, the current study
observed a significant difference in IL-1β-511
frequency between NSCLC and healthy
Egyptian subjects. In agreement with our
results, Zienolddiny et al. (2004) confirmed that
the IL-1β polymorphisms were markedly linked
to lung cancer susceptibility in the Norwegian
population. The study included 251 lung cancer
cases and 271 healthy volunteers, which were
largely different among IL-1β-511 genotypes
and allotypes. The nested case-control study of
Eaton et al. (2018) conducted on contributors
from the β-Carotene and Retinol Efficacy Trial
discovered that the rs16944 variant was
associated with the lung cancer incidence (p =
0.03). A recent meta-analysis was designed to
explore the impact of 11 different variants of IL1β, IL-4, IL-6, IL-8, and IL-10 from 43 studies
on lung cancer susceptibility. The study
selected 12 case-controlled studies for the
rs16944 SNP and indicated that its allelic and
genotypic frequencies were significantly linked
to lung cancer susceptibility (Ding et al., 2021).
On the contrary, other studies by Li and Wang,
Pérez-Ramírez et al., and Kiyohara et al. (2013;
2017; 2014) showed that there was a nonsignificant difference in the rs16944 variant
between lung cancer cases and controls.
Thus, the overall findings suggest the
significance
of
the
IL-1β
rs16944
polymorphism in NSCLC occurrence.
However, the study comprised limited samples
collected from a single center. Therefore, it is
important to design further studies in other
ethnic populations with larger sample sizes to
support our findings.
Conclusion
In conclusion, this pioneering study
illustrated the association between IL-1β511C>T polymorphism and NSCLC in
Egyptian subjects. Our work indicated that the
IL-1β-511C>T genotypes were significantly
different in NSCLC compared to the healthy
12
Association of IL-6 rs1800795 and IL-1 β rs16944 …
Scientific Journal for Damietta Faculty of Science 13(3) 2023, 8-15
and lung cancer risk. Cancer Epidemiol
Biomarkers
Prev.
14(2):538–9.
https://doi.org/10.1158/1055-9965.EPI-04-0513.
Silva EM, Mariano VS, Pastrez PRA, Pinto MC,
Castro AG, Syrjanen KJ, Longatto-Filho A
(2017) High systemic IL-6 is associated with
worse prognosis in patients with non-small cell
lung cancer. PLoS One. 12(7):e0181125.
https://doi.org/10.1371/journal.pone.0181125.
Padrón-Morales J, García-Solaesa V, Isidoro-García
M, Hernández-Hernández L, García-Sánchez A,
Hincapié-López G, Lorente-Toledano F, Dávila
I, Sanz C (2014) Implications of cytokine genes
in allergic asthma. Allergol Immunopathol
(Madr).
42(6):603–8.
https://doi.org/10.1016/j.aller.2013.11.006.
González-Castro TB, Hernández-Díaz Y, PérezHernández N, Tovilla-Zárate CA, Juárez-Rojop
IE, López-Narvaez ML, Blachman-Braun R,
Posadas-Sánchez R, Vargas-Alarcón G, GarcíaFlores E, Cazarín-Santos BG, Borgonio-Cuadra
VM, Reyes-López PA, Rodríguez-Pérez JM
(2019) Interleukin 6 (RS1800795) gene
polymorphism is associated with cardiovascular
diseases: a meta-analysis of 74 studies with
86,229 subjects. EXCLI J. 18:331–55.
https://doi.org/10.17179/excli2019-1248.
Harun-Or-Roshid M, Ali MB, Jesmin, Mollah MNH
(2021) Statistical meta-analysis to investigate the
association between the interleukin-6 (IL-6) gene
polymorphisms and cancer risk. PLoS One.
16(3):e0247055.
https://doi.org/10.1371/journal.pone.0247055.
Almolakab ZM, El-Nesr KA, Mohamad Hassanin
EH, Elkaffas R, Nabil A (2022) Gene
polymorphisms of Interleukin 6 (−174 G/C) and
transforming growth factor β-1(+915 G/C) in
ovarian cancer patients. Beni-Suef Univ J Basic
Appl Sci. 11:30. https://doi.org/10.1186/s43088022-00211-5.
Zhai K, Yang Y, Gao ZG, Ding J (2017) Interleukin6-174G>C gene promoter polymorphism and
prognosis in patients with cancer. Oncotarget.
8(27):44490-97.
https://doi.org/10.18632/oncotarget.17771.
Eaton KD, Romine PE, Goodman GE, Thornquist
MD, Barnett MJ, Petersdorf EW (2018)
Inflammatory gene polymorphisms in lung
cancer susceptibility. J Thorac Oncol.
13(5):649–59.
https://doi.org/10.1016/j.jtho.2018.01.022.
Li C, Wang C (2013) Current evidences on IL1B
polymorphisms and lung cancer susceptibility: a
meta-analysis. Tumor Biol. 34(6):3477–82.
https://doi.org/10.1007/s13277-013-0925-6.
Li Y, Zhao W, Zhao Z, Wu J, Chen L, Ma Y, Li Q,
Lu D, Jin L, Wang J (2015) IL1B gene
polymorphisms, age and the risk of non-small
volunteers. However, the IL-6-174G>C SNP
was not significantly associated with the
development of NSCLC. This study shed light
on the role of IL-1β gene polymorphism in the
earlier prevention of developing lung cancer as
a candidate genetic marker.
Declaration of competing interest
All authors declare that there is no conflict of
interest between them.
References
Kaanane H, Senhaji N, Berradi H, Benchakroun N,
Benider A, Karkouri M, El Attar H, Flores O,
Khyatti M, Nadifi S (2022) The influence of
Interleukin-6, Interleukin-8, Interleukin-10,
Interleukin-17, TNF-A, MIF, STAT3 on lung
cancer risk in Moroccan population. Cytokine.
151:155806.
https://doi.org/10.1016/j.cyto.2022.155806.
El-Moselhy EA, Elrifai AW (2018) Risk factors of
lung cancer worldwide and in Egypt: current
situation. J Oncopathol Clin Res. 2(2): 5.
Duma N, Santana-Davila R, Molina JR (2019) Nonsmall cell lung cancer: epidemiology, screening,
diagnosis, and treatment. Mayo Clin Proc.
94(8):162340. https://doi.org/10.1016/j.mayocp.2019.01.01
3.
Landvik NE, Hart K, Skaug V, Stangeland LB,
Haugen A, Zienolddiny S (2009) A specific
interleukin-1B haplotype correlates with high
levels of IL1B mRNA in the lung and increased
risk of non-small cell lung can. Carcinogenesis.
30(7):1186-92.
https://doi.org/10.1093/carcin/bgp122.
Tan Z, Xue H, Sun Y, Zhang C, Song Y, Qi Y (2021)
The
role
of
tumor
inflammatory
microenvironment in lung cancer. Front
Pharmacol.
12:688625. https://doi.org/10.3389/fphar.2021.6
88625.
Dutkowska A, Szmyd B, Kaszkowiak M,
Domańska-Senderowska
D,
PastuszakLewandoska D, Brzeziańska-Lasota E, Kordiak
J, Antczak A (2021) Expression of inflammatory
interleukins and selected miRNAs in non-small
cell lung cancer. Sci Rep. 11(1):5092.
https://doi.org/10.1038/s41598-021-84408-1.
Campa D, Hung RJ, Mates D, Zaridze D, SzeszeniaDabrowska N, Rudnai P, Lissowska J, Fabiánová
E, Bencko V, Foretova L, Janout V, Boffetta P,
Brennan P, Canzian F (2005) Lack of association
between polymorphisms in inflammatory genes
13
Association of IL-6 rs1800795 and IL-1 β rs16944 …
Scientific Journal for Damietta Faculty of Science 13(3) 2023, 8-15
cell lung cancer in a Chinese population. Lung
Cancer.
89(3):232–7.
https://doi.org/10.1016/j.lungcan.2015.06.009.
Zienolddiny S, Ryberg D, Maggini V, Skaug V,
Canzian F, Haugen A (2004) Polymorphisms of
the interleukin-1 β gene are associated with
increased risk of non-small cell lung cancer. Int J
Cancer.
109(3):353–6.
https://doi.org/10.1002/ijc.11695.
Bhat IA, Naykoo NA, Qasim I, Ganie FA, Yousuf
Q, Bhat BA, Rasool R, Aziz SA, Shah ZA (2014)
Association of interleukin 1 beta (IL-1β)
polymorphism with mRNA expression and risk
of non small cell lung cancer. Meta Gene. 2:123–
33.
https://doi.org/10.1016/j.mgene.2013.12.002.
Elsaid A, Abdel-Aziz AF, Elmougy R, Elwaseef AM
(2014) Association of polymorphisms G(-174)C
in IL-6 gene and G(-1082)A in IL-10 gene with
traditional cardiovascular risk factors in patients
with coronary artery disease. Indian J Biochem
Biophys. 51(4):282–92.
Okayama N, Hamanaka Y, Suehiro Y, Hasui Y,
Nakamura J, Hinoda Y (2005) Association of
interleukin-10 promoter single nucleotide
polymorphisms -819 T/C and -592 A/C with
aging. J Gerontol A Biol Sci Med Sci.
60(12):1525–9.
https://doi.org/10.1093/gerona/60.12.1525.
Bai L, Yu H, Wang H, Su H, Zhao J, Zhao Y (2013)
Genetic single-nucleotide polymorphisms of
inflammation-related factors associated with risk
of lung cancer. Med Oncol. 30(1):414.
https://doi.org/10.1007/s12032-012-0414-6.
de Groot PM, Wu CC, Carter BW, Munden RF
(2018) The epidemiology of lung cancer. Transl
Lung
Cancer
Res.
7(3):220–33.
https://doi.org/10.21037/tlcr.2018.05.06.
North CM, Christiani DC (2013) Women and lung
cancer: what is new? Semin Thorac Cardiovasc
Surg.
25(2):87-94.
https://doi.org/10.1053/j.semtcvs.2013.05.002.
Gao J, Ying Y, Wang J, Cui Y, Zhang W (2020)
Certain interleukin polymorphisms might
influence predisposition to lung cancer: a metaanalysis of 35 published studies. IUBMB Life.
72(5):957–64. https://doi.org/10.1002/iub.2228.
Liu Y, Song XL, Zhang GL, Peng AM, Fu PF, Li P,
Tan M, Li X, Li M, Wang CH (2015) Lack of
association
between
IL-6
-174G>C
polymorphism and lung cancer: a meta-analysis.
Genet
Mol
Res.
14(1):163–9.
https://doi.org/10.4238/2015.January.15.19.
Tian G, Mi J, Wei X, Zhao D, Qiao L, Yang C, Li X,
Zhang S, Li X, Wang B (2015) Circulating
interleukin-6 and cancer: a meta-analysis using
Mendelian randomization. Sci Rep. 5:11394.
https://doi.org/10.1038/srep11394.
Peng X, Shi J, Sun W, Ruan X, Guo Y, Zhao L,
Wang J, Li B (2018) Genetic polymorphisms of
IL-6 promoter in cancer susceptibility and
prognosis: a meta-analysis. Oncotarget.
9(15):12351–64.
https://doi.org/10.18632/oncotarget.24033.
Ding K, Yi M, Li L, Zhang Y (2021) Interleukin
polymorphisms and protein levels associated
with lung cancer susceptibility and phenotypes.
Expert Rev Clin Immunol. 17(9):1029–40.
https://doi.org/10.1080/1744666X.2021.195207
2.
Pérez-Ramírez C, Alnatsha A, Cañadas-Garre M,
Villar E, Valdivia-Bautista J, Faus-Dáder MJ,
Calleja-Hernández MÁ (2017) Cytokine singlenucleotide polymorphisms and risk of non-smallcell lung cancer. Pharmacogenet Genomics.
27(12):438–44.
https://doi.org/10.1097/FPC.000000000000030
7.
Kiyohara C, Horiuchi T, Takayama K, Nakanishi Y
(2014) Genetic polymorphisms involved in the
inflammatory response and lung cancer risk: a
case-control study in Japan. Cytokine. 65(1):88–
94. https://doi.org/10.1016/j.cyto.2013.09.015.
الملخص العربي
بسرطان الرئة ذو الخاليا غير
3السعيد
IL-1β (rs16944) وIL-6 (rs1800795)
ارتباط تعدد أشكال:عنوان البحث
دراسة تجريبية:الصغيرة في السكان المصريين
عفاف،2 شريف رفعت،1 رنا رمزي الصدة،1 رشا فكري زهران،1*يمنى فوزي متولي
مصر، جامعة دمياط، كلية العلوم، قسم الكيمياء1
مصر، المنصورة، جامعة المنصورة، مركز األورام، قسم األورام2
مصر، المنصورة، جامعة المنصورة، مستشفى األطفال، وحدة الوراثة3
وقد اكدت.سرطان الرئة هو مشكلة صحية وحياتية خطيرة وذلك لكونه يسبب أعلى معدالت اإلصابة بالسرطان والوفيات في العالم
14
Scientific Journal for Damietta Faculty of Science 13(3) 2023, 8-15
… Association of IL-6 rs1800795 and IL-1 β rs16944
الدراسات أن االلتهاب له دور رئيسي في حدوث السرطان ،وال سيما ظهور سرطان الرئة .لذا تهدف هذه الدراسة الى اكتشاف دور
تعدد األشكال ( )polymorphismsللجينات المسؤولة عن االلتهاب بزيادة اإلصابة بسرطان الرئة .في هذه الدراسة تم عمل
استخالص للحمض النووي DNAلكل من مرضى سرطان الرئة ذو الخاليا غير الصغيرة ( )NSCLCواألشخاص االصحاء
المصريين ومن ثم تم تحديد النمط الجيني لكل من جينيي ) IL-6 (rs1800795و) IL-1β (rs16944باستخدام تقنية ARMS-(.
) PCRاثبتت الدراسة ان تعدد االشكال الجينية للجين ) IL-1β (rs16944له عالقه قوية باإلصابة بمرض .NSCLCاال ان
اختالف االشكال لجين ) IL-6 (Rs1800795ليس له عالقة باإلصابة بمرض NSCLCمقارنة باألشخاص االصحاء .ومن
الجدير بالذكر ان هذه هي الدراسة األولى التي القت الضوء على عالقة تعدد أشكال جين ) IL-1β (rs16944بزيادة االصابة
بسرطان الرئة غير صغير الخاليا ( )NSCLCفي السكان المصريين .وبالتالي ،قد يكون ا
دليال داع اما للوقاية المبكرة من سرطان
الرئة غير صغير الخاليا (.)NSCLC
15